United States· US:67296-2129_4698d4e7-2e86-6fbf-e063-6294a90a0d1e
Moxifloxacin
A moxifloxacin product containing moxifloxacin hydrochloride monohydrate, registered in United States by Redpharm Drug. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Moxifloxacin is registered in 12 of 19 countries.
Countries holding a registration under ATC S01AE07 (moxifloxacin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Moxifloxacin · ATC S01AE07
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE
- Manufacturer
- Redpharm Drug
- Country
- United States (US)
- ATC code
- S01AE07
- ATC class
- Moxifloxacin
- Defined daily dose
- 0.57 mg, AT
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1167296-2129-3
- ndc1167296212931 BOTTLE in 1 CARTON (67296-2129-3) / 3 mL in 1 BOTTLE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Moxifloxacin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandFlomixaFarmak International Sp. z o.o.
- CzechiaMOXIFLOXACIN BROWN & BURKBrown & Burk IR Limited, Dublin
- NetherlandsMoxifloxacine Stulln 5 mg/ml oogdruppels, oplossingPharma Stulln GmbH
- SwedenVigamox 5 mg/ml Ögondroppar, lösningNovartis Sverige AB
- BelgiumKanavig 5 mg/mlNovartis Pharma
- NorwayVigamoxNovartis
- IcelandVigamoxNovartis Healthcare A/S
- FinlandVigamoxNovartis Finland Oy
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Avelox, Moxifloxacin 1a Pharma
- Belgium · Avelox, Kanavig
- Bulgaria · Cimocinox, Moxifloxacin Kabi
- Cyprus · Avelox, Erelan
- Czechia · Avelox, Moxifloxacin Brown & Burk
- Germany · Avalox, Moxifloxacin 1 A Pharma
- Denmark · Moxifloxacin Accord, Moxifloxacin Fresenius Kabi
- Estonia · Avelox, Floxelan
- Spain · Abimox, Actira
- Finland · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- France · Izilox, Moxifloxacine Arrow
- United Kingdom (Northern Ireland) · Avelox, Moxidox
- Greece · Avelox, Mikrobiel
- Croatia · Melvedok, Moksacin 5 Mg/Ml Kapi
- Hungary · Moxibiot, Moxifloxacin Anfarm
- Ireland · Moxifloxacin
- Iceland · Vigamox
- Italy · Avalox, Moxidrop
- Lithuania · Avelox, Ekara
- Luxembourg · Avelox, Kanavig
- Latvia · Avelox, Ekara
- Malta · Erelan, Moxifloxacin Anfarm
- Netherlands · Erelan, Moxifloxacin Hydrochloride Aurobindo
- Norway · Xinaflox
- Poland · Flomixa, Floxamic Neo
- Portugal · Avelox, Bluesar
- Romania · Avelox, Kimoks
- Sweden · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- Slovenia · Kimoks, Moksifloksacin Kabi
- Slovakia · Avelox, Moloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad18302b-61ab-41a6-befc-1cc9fb10b07c GET /v1/drugs/ad18302b-61ab-41a6-befc-1cc9fb10b07c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "5",
"substance": "MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE",
"productndc": "67296-2129",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA202867",
"marketing_category": "ANDA"
}See everything about moxifloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.